Pluri Signs Manufacturing Deal with Kadimastem
Pluri Inc., a biotechnology company, has signed a tech transfer and manufacturing agreement with Kadimastem Ltd., a clinical stage biotechnology company developing therapeutic cells for ALS…
Pluri Inc., a biotechnology company, has signed a tech transfer and manufacturing agreement with Kadimastem Ltd., a clinical stage biotechnology company developing therapeutic cells for ALS…
Pluri Inc., a biotechnology firm based in Haifa, Israel, recently announced the launch of two new business verticals. These are PluriAgtech and PluriCDMO, aimed at leveraging…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.